Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Halse

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation|October 22, 2010
Effect of loss of regional fat assessed by DXA on insulin resistance and dyslipidaemia in obese menGunnar Aasen, Hans Fagertun, Johan Halse
Scandinavian Journal of Clinical and Laboratory Investigation|April 13, 2010
Effect of regional fat loss assessed by DXA on insulin resistance and dyslipidaemia in obese womenGunnar Aasen, Hans Fagertun, Johan Halse
Acta Obstetricia Et Gynecologica Scandinavica|June 1, 2012
New developments in the treatment of osteoporosisErik Fink Eriksen, Johan Halse, Mette Haase Moen
Scandinavian Journal of Clinical and Laboratory Investigation|October 22, 2008
Leg fat mass as measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus menGunnar Aasen, Hans Fagertun, Serena Tonstad, et al.
The American Journal of Clinical Nutrition|May 26, 2004
Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humansJean-Michel Gaullier, Johan Halse, Kjetil Høye, et al.
The Journal of Nutrition|March 30, 2005
Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humansJean-Michel Gaullier, Johan Halse, Kjetil Høye, et al.
Current Medical Research and Opinion|July 12, 2005
The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosisHarry K Genant, Johan Halse, Walter G Briney, et al.
Clinical Therapeutics|November 24, 2007
Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trialMatti J Välimäki, Jordi Farrerons-Minguella, Johan Halse, et al.
The British Journal of Nutrition|February 23, 2007
Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obeseJean-Michel Gaullier, Johan Halse, Hans Olav Høivik, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 2, 2005
Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatmentRichard Prince, Adrien Sipos, Anwar Hossain, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Scandinavian Journal of Clinical and Laboratory Investigation|October 22, 2010
Effect of loss of regional fat assessed by DXA on insulin resistance and dyslipidaemia in obese menGunnar Aasen, Hans Fagertun, Johan Halse
Scandinavian Journal of Clinical and Laboratory Investigation|April 13, 2010
Effect of regional fat loss assessed by DXA on insulin resistance and dyslipidaemia in obese womenGunnar Aasen, Hans Fagertun, Johan Halse
Acta Obstetricia Et Gynecologica Scandinavica|June 1, 2012
New developments in the treatment of osteoporosisErik Fink Eriksen, Johan Halse, Mette Haase Moen
Scandinavian Journal of Clinical and Laboratory Investigation|October 22, 2008
Leg fat mass as measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus menGunnar Aasen, Hans Fagertun, Serena Tonstad, et al.
The American Journal of Clinical Nutrition|May 26, 2004
Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humansJean-Michel Gaullier, Johan Halse, Kjetil Høye, et al.
The Journal of Nutrition|March 30, 2005
Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humansJean-Michel Gaullier, Johan Halse, Kjetil Høye, et al.
Current Medical Research and Opinion|July 12, 2005
The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosisHarry K Genant, Johan Halse, Walter G Briney, et al.
Clinical Therapeutics|November 24, 2007
Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trialMatti J Välimäki, Jordi Farrerons-Minguella, Johan Halse, et al.
The British Journal of Nutrition|February 23, 2007
Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obeseJean-Michel Gaullier, Johan Halse, Hans Olav Høivik, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 2, 2005
Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatmentRichard Prince, Adrien Sipos, Anwar Hossain, et al.
Pageof 3